Exendin‐4 shows no effects on the prostatic index in high‐fat‐diet‐fed rat with benign prostatic hyperplasia by improving insulin resistance

Publisher： John Wiley & Sons Inc

E-ISSN： 1439-0272|47|2|236-242

ISSN： 0303-4569

Source： ANDROLOGIA (ELECTRONIC), Vol.47, Iss.2, 2015-03, pp. : 236-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tadalafil Monotherapy for Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-08 ,pp. : 487-488

Karger

Access to resources Recommend Favorite

Benign Prostatic Hyperplasia: Diagnosis and Treatment

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1163-1165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Body Mass Index Predicts Failure of Surgical Management in Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 90, Iss. 2, 2012-12 ,pp. : 150-155

Karger

Access to resources Recommend Favorite

High-Energy Microwave Thermotherapy in the Treatment of Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 71, Iss. 1, 2003-07 ,pp. : 10-15

Karger

Access to resources Recommend Favorite

The Use of a Prostatic Stent in High Risk Patients over 80 Years Old with Benign Prostatic Hyperplasia and Chronic Retention

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 9, 1994-09 ,pp. : 1004-1005

John Wiley & Sons Inc

Access to resources Recommend Favorite